Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol.
about
Identification of inherited genetic variations influencing prognosis in early-onset breast cancer2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.Support Vector Machine classifier for estrogen receptor positive and negative early-onset breast cancer.Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer.Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyQuantifying the cumulative effect of low-penetrance genetic variants on breast cancer risk.The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.Common germline polymorphisms associated with breast cancer-specific survival.BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years.Identification of novel genetic markers of breast cancer survival.Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy.The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer.Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study.Obesity and the outcome of young breast cancer patients in the UK: the POSH study.Deep sequencing reveals the mitochondrial DNA variation landscapes of breast-to-brain metastasis blood samples.Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer: The POSH Observational Cohort Study.Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02).Family history and outcome of young patients with breast cancer in the UK (POSH study).Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women.Composite likelihood-based meta-analysis of breast cancer association studies.Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.Genetic testing in a cohort of young patients with HER2-amplified breast cancer.
P2860
Q28943279-664CA47C-9063-41F3-94CB-016DA8121414Q33848895-BD9F58C3-F4AB-4A4B-B072-ACA754EB28ABQ34744122-A26E694D-9306-4D6F-8A37-D137BA9D481EQ34872901-656695AE-B8BC-452A-B23F-AF95CE7695A2Q35020403-DAFF6909-A6B2-488D-8DA8-0B57C2C9D729Q35022847-6871338F-4B54-4E27-B035-390E66D0979DQ35198352-474E83F9-76D2-40AF-9601-02BF80D7343AQ35218520-036198CC-3C32-4A20-B29D-E0F6BBB0B532Q35648055-3ABCC0C4-75E1-4B9F-9D25-585A9488F18EQ35781316-C30F1588-B382-4BD6-9678-89FDA95D45A1Q35794653-E1645F47-2844-4DAE-9E00-2E175A8DF267Q35832295-E34EC03B-0368-47F3-A112-239BD6F230D5Q36014067-0925A2BE-347B-4913-BC93-31059B9288A6Q36071595-DA4841B3-CC83-4485-97A0-415EEBC03AE0Q37131378-1CD637ED-C1BE-4051-9FAD-49F012A23CC9Q37459580-CA94AFC1-C31D-4627-ACC7-E65ACD1A7DA0Q38303253-6D88C2F3-2315-42DB-B9FD-2E6D950ED1B2Q38369233-9790CD27-57C8-4EA1-B9F1-F7AF705DF983Q39562817-9AAC5B69-9F20-4DC9-AED8-D6626E32F3ABQ40115245-F691FE4F-2489-455C-B02E-97CD8056ABCAQ40923313-E921E437-108C-451D-98C5-3F23C2ADB8ADQ44358008-1467B923-C530-4713-8A1E-20012E3A5E2CQ45733546-7730C66B-B820-49B1-A58A-923E47317670Q46084460-5DB666E9-2EF1-4861-9F36-5EA88E2FC8E7Q47552886-84799BB9-2B54-4158-A8AD-F425A4703A13Q52642370-04CC42DE-2F51-41D4-872E-69A801963722Q54227575-D534B379-8992-478F-A2B7-696EC3C192D0
P2860
Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prospective study of Outcomes ...... cancer (POSH): study protocol.
@ast
Prospective study of Outcomes ...... cancer (POSH): study protocol.
@en
type
label
Prospective study of Outcomes ...... cancer (POSH): study protocol.
@ast
Prospective study of Outcomes ...... cancer (POSH): study protocol.
@en
prefLabel
Prospective study of Outcomes ...... cancer (POSH): study protocol.
@ast
Prospective study of Outcomes ...... cancer (POSH): study protocol.
@en
P2093
P2860
P356
P1433
P1476
Prospective study of Outcomes ...... cancer (POSH): study protocol.
@en
P2093
POSH steering group
Peter Simmonds
Sarah Ennis
Victoria Hammond
P2860
P2888
P356
10.1186/1471-2407-7-160
P407
P577
2007-08-15T00:00:00Z
P5875
P6179
1025907121